Ivan Tornos
Chairman, President and Chief Executive Officer
Executive
3 yr
13 reports
Zimmer Biomet Holdings, Inc. ·ZBH
Enterprise structure led by three regional presidents
Health Care · Fortune #483 · Hybrid structure · 17K employees · Warsaw, Indiana
View as of:
6
CEO span
↓ tighter than peers (avg 10)
1.6
Avg span
tight
3
Max depth
3 levels
1.7 yr
Avg tenure
↓ 1.7yr from FY2024
33%
Internal hires
↓ below industry avg
Consolidated financials FY2025 · period end 2025-12-31 · 10-K
Revenue
$8.2B
Operating income
$1.1B
Net income
$705M
Total assets
$23.1B
Shares out
196M
Sourced from Zimmer Biomet Holdings, Inc. DEF 14A · filed 2026-04-01 ↗ View on SEC
Interactive org chart
Zimmer Biomet Holdings, Inc. organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Enterprise structure led by three regional presidents reporting to the CEO. This page maps Zimmer Biomet’s executive org, recent CFO transition, leadership analysis, and peer comparison for its global medical device operations.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal Suketu Upadhyay departed as Chief Financial Officer
Resigned effective April 28, 2026.
Source · See change logScenario views in the chart
- Appoint Permanent CFO Replace the interim CFO with a permanent finance leader to stabilize long-term capital strategy.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
7 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
Jehanzeb Noor
SVP, Chief Strategy, Business Development, Innovation and Transformation Officer
Strategy
1 yr
2 reports
Kevin Thornal
Group President, Global Businesses and the Americas
Commercial
1 yr
2 reports
internal
Paul Stellato
Interim Chief Financial Officer
Finance
0 yr
1 reports
Wilfred van Zuilen
Group President, Europe, Middle East and Africa
Commercial
2 yr
1 reports
Lori Winkler
Senior Vice President, Chief Human Resources Officer
Human Resources
5 yr
1 reports
internal
Chad F. Phipps
Senior Vice President, Chief Legal and Corporate Affairs Officer
Legal
0 yr
0 reports
The pay
Executive compensation
From the most recent DEF 14A Summary Compensation Table. 2 named executive officers disclosed. Bar length scales with total compensation.
Ivan Tornos $16.1M
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
Suketu Upadhyay $6.2M
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
The skin in the game
Beneficial ownership
Insider stock holdings and the company's ownership requirements for executives and directors. Disclosed in the most recent DEF 14A.
Stock ownership requirements
6×CEO base salary
3×NEO base salary
5×Director cash retainer
Robust stock ownership guidelines disclosed in proxy.
The businesses
How Zimmer Biomet Holdings, Inc. divides the work
5 divisions report into the group CEO. Tile size scales with estimated headcount.
Finance
800 employees
Interim CFO (Paul Stellato)
Oversees global finance, accounting, FP&A, and controls.
Strategy & Innovation
600 employees
Chief Strategy Officer (Jehanzeb Noor)
Leads corporate strategy, M&A, R&D, and enterprise transformation.
Americas Commercial
7K employees
Group President, Global Businesses and the Americas (Kevin Thornal)
Manages U.S. and Americas sales, marketing, and operations.
EMEA Commercial
4K employees
Group President, EMEA (Wilfred van Zuilen)
Oversees sales and distribution across Europe, Middle East, and Africa.
Human Resources
300 employees
Chief Human Resources Officer (Lori Winkler)
Leads global talent, compensation, and succession planning.
The thesis
Why this org is unusual
Zimmer Biomet’s most distinctive feature is its enterprise model built around three powerful regional and commercial presidents reporting directly to the CEO.
The CEO has six direct reports, with commercial leadership split between Americas, EMEA, and enterprise-wide strategy rather than product-line CEOs.
This structure reflects Zimmer Biomet’s emphasis on geographic execution and scale in regulated markets. Strategy, R&D, and transformation are centralized under a single chief strategy officer, while finance is temporarily stabilized under an interim CFO following the April 2026 resignation.
Compared with peers, Zimmer Biomet runs relatively lean at the top, with only one enterprise strategy role overseeing both M&A and R&D, and no permanent CFO as of 2026-Q2.
- Interim CFO in place
- Centralized R&D under strategy
- Chairman and CEO roles combined
The comparison
How Zimmer Biomet Holdings, Inc. stacks up
Relative to peers such as Stryker and Boston Scientific, Zimmer Biomet maintains a more centralized enterprise structure with fewer product-division CEOs. Competitors often allocate full P&L ownership to orthopedic sub-franchises, whereas Zimmer Biomet emphasizes regional scale and centralized innovation. The …
C-suite size
Reporting depth
Zimmer Biomet Holdings, Inc.
3 levels
5 levels
5 levels
Medtronic
6 levels
Johnson & Johnson
6 levels
Avg C-suite tenure
Has COO / Has CAIO
Zimmer Biomet Holdings, Inc. — no COO — no CAIO
Medtronic ✓ COO ✓ CAIO
Johnson & Johnson — no COO ✓ CAIO
Current signals
What changed recently
CFO Suketu Upadhyay resigned in April 2026, with Paul Stellato named interim CFO.
- departed
- new
- departed
Leadership Timeline
Year-over-year executive structure based on SEC proxy and annual filings.
FY2025
DEF 14A filed 2026-04-01
- CEO
- Ivan Tornos
- CEO span
- 5
- C-suite
- 5
- Avg tenure
- 2.1 yr
Leadership stabilized post-CEO transition with new strategy chief.
Named executive officers (5)
- Ivan Tornos - CEO since 2023
- Suketu Upadhyay - CFO since 2019
- Kevin Thornal - Group President, Americas since 2025
- Jehanzeb Noor - Chief Strategy Officer since 2025
- Wilfred van Zuilen - Group President, EMEA since 2021
FY2024
DEF 14A filed 2025-04-01
- CEO
- Ivan Tornos
- CEO span
- 6
- C-suite
- 6
- Avg tenure
- 3.4 yr
Expanded enterprise roles following CEO appointment.
Named executive officers (3)
- Ivan Tornos - CEO since 2023
- Suketu Upadhyay - CFO since 2019
- Wilfred van Zuilen - Group President, EMEA since 2021
FY2023
DEF 14A filed 2024-04-01
- CEO
- Ivan Tornos
- CEO span
- 5
- C-suite
- 5
- Avg tenure
- 4.2 yr
CEO transition year from prior leadership.
Named executive officers (2)
- Ivan Tornos - CEO since 2023
- Suketu Upadhyay - CFO since 2019
Year-over-year changes
2025 added a new strategy chief and Americas president, reshaping the enterprise team.
- CEO span: 5 → 6
- C-suite size: 6 → 5
- Avg tenure: 3.4 → 2.1 yr
- new Kevin Thornal - Group President, Global Businesses and the Americas (DEF 14A 2026-04-01)
- new Jehanzeb Noor - Chief Strategy Officer (DEF 14A 2026-04-01)
The board
Board of directors
3 directors. 2 of 3 independent (67%). Source: most recent DEF 14A.
Ivan Tornos
Chair Inside
Chairman, President and CEO, Zimmer Biomet
Also on: PHC Holdings Corporation
Michael J. Farrell
Lead Indep. Independent
Chair and CEO, ResMed Inc.
Betsy J. Bernard
Independent
Retired President, AT&T Corp.
The board, organized
Board committees
1 standing committees. Audit and Compensation must be 100% independent under SEC rules; the rest vary.
Audit Committee
100% independent
Frequently Asked Questions
Who is the CEO of Zimmer Biomet Holdings?
Ivan Tornos has served as Chairman, President, and CEO since August 2023.
What type of organizational structure does Zimmer Biomet Holdings use?
Zimmer Biomet operates a hybrid enterprise structure centered on regional presidents and centralized strategy.
How many direct reports does Zimmer Biomet Holdings's CEO have?
The CEO has six direct executive reports.
How has Zimmer Biomet Holdings's leadership changed recently?
In April 2026, CFO Suketu Upadhyay resigned and Paul Stellato was appointed interim CFO.
Who reports directly to Zimmer Biomet Holdings's CEO?
Direct reports include the interim CFO, chief strategy officer, two regional presidents, the CHRO, and chief legal officer.
Sources
- 8-K Filing, Apr 28 2026
- 8-K Filing, Jan 12 2026
- SEC EDGAR: Zimmer Biomet Holdings, Inc. DEF 14A Proxy Statement
- SEC EDGAR: Zimmer Biomet Holdings, Inc. 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). Zimmer Biomet Holdings, Inc. organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/zimmer-biomet-holdings/MLA 9th
"Zimmer Biomet Holdings, Inc. Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/zimmer-biomet-holdings/. Accessed .Chicago 17
Creately. "Zimmer Biomet Holdings, Inc. Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/zimmer-biomet-holdings/.Original SEC source View on SEC ↗
Zimmer Biomet Holdings, Inc.. DEF 14A. Filed 2026-04-01. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1136869/000119312526135661/zbh-20260331.htmPermanent URL: https://creately.com/org-chart/fortune-500/zimmer-biomet-holdings/ · last updated 2026-04-01